top of page

Iris/Ciliary Tumour Overview

Introduction

The uveal tract is highly vascular, and thus accounts for 11% of ocular tumours. These tumours can include:
- Various benign iris nodules and lumps often associated with syndromes or systemic conditions.
- Cysts (stromal, epithelial) represents ~20% of all tumours
- Iris naevi, melanocytoma
- Iris and ciliary body melanoma
- Other rare tumours such as leiomyoma, haemangioma, lung/breast cancer metastasis

Dead Giveaways

Iris Tumours

Small Benign Iris Lesions:

  • Freckles: Smaller than naevi and occurs at the surface layer only, not stroma

  • Bruschfield Spots: Pale lesions peripheral iris stroma, often patients with Trisomy 21

  • Mamillations: Unilateral tiny villiform lesions; uncommon but in patients with congenital ocular melanocytosis, Axenfeld and Peter’s anomaly

  • Lisch Nodules: Small bilateral nodules after ~16yrs in most Px with NF1


Benign Iris Naevus and Melanocytoma:

  • Flat (<3mm diameter, <0.5mm thick)

  • Mostly pigmented, usually no growth → surface proliferation of melanocyte

  • Typically, melanocytomas are benign lesions formed by melanocytes with dense pigments

  • May disrupt normal iris structure or distort pupil (ectropion uveae)


Iris and CIliary Body Melanoma:

  • Uveal melanomas ~3% (cf. ciliary body 10%, choroid 85%)

  • Often asymptomatic and seen around age ~50-60 years.

  • Can be diffuse, nodular or sometimes a ring affecting the whole iris

  • Usually affects the inferior iris, with prominent feeder vessels

    • Details of the iris are lost, such as the crypts

    • Can also distort the pupil

    • Generally, the prognosis is good with only 5% developing metastasis in 10 years


Non-melanocytic Iris Tumours:

  • Iris vascular tumours like haemangiomas more obvious under OCT-A which reveals tortuous vessels

  • Iris juvenile xanthogranuloma

  • Iris lymphoid tumour

  • Iris metastasis from breast or remote cancer


Iris Pigment Epithelium Adenoma

  • Rare benign tumour, grey-black nodule with smooth surface, often peripherally, causing anterior displacement and stromal thinning


Ciliary Body Tumours

Ciliary Body Melanoma:

  • Rare, ~8-10% of uveal melanomas and can often extend to choroid

  • Very aggressive cf. iris

    • Good to look for the scleral sentinal vessels or external tumour

      Nodule with sentinel scleral vessels
      Nodule with sentinel scleral vessels
    • Asymptomatic until complications arise, such as glaucoma and VF loss

    • Detection is fairly late, and prognosis typically poor due to metastatic risk


Other Ciliary Body Tumours:

  • Leiomyoma = very rare smooth muscle tumour, affecting ciliary body, iris and anterior chamber

    • Minimal intra/extraocular extension, low mitotic rate

    • More common in younger women and asymptomatic until it affects nearby structures

    • Blurred vision, floaters and sometimes pain

  • Medulloepithelioma = very rare, unilateral embryonic tumour that occurs in first decade

diagnostic features

ABCDEF Grading System: (progression from naevus to melanoma)

  • A: Age < 40 years

  • B: Blood or hyphaema

  • C: Clock Hours Inferior

  • D: Diffuse

  • E: Ectropion

  • F: Feathery Edges


Predisposing factors to melanoma

  • Fair skin or light iris colour

  • Cutaneous naevi

  • Pigmented conditions such as congenital ocular melanocytosis, naevus of Ota, uveal melanocytoma, dysplastic skin melanoma, NF1

  • UV


Referrals:

  • Ophthalmologist/ocular oncologist, oculoplastics + pathology, medical oncology


Tx:

  • Surgical excision, radiotherapy, enucleation for diffuse painful eyes.

  • Metastatic melanomas: immunotherapy trials.

2025, made by Eric Qin. UNSW. SOVS

bottom of page